A study by Rubin et al. 14, similarly demonstrated overexpression of AMACR in prostate cancer, evaluation of AMACR protein expression in 94 prostate needle biopsy specimens demonstrated 97% sensitivity and 100% specificity for detecting prostate cancer. Here, AMACR is linked to prostate carcinoma.